The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic

被引:396
作者
Montaner, Julio S. G.
Hogg, Robert
Wood, Evan
Kerr, Thomas
Tyndall, Mark
Levy, Adrian R.
Harrigan, P. Richard
机构
[1] Univ British Columbia, British Columbia Ctr Excellence HIV AIDS, Prov Hlth Care, Vancouver, BC V5Z 1M9, Canada
[2] Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada
[3] Univ British Columbia, Dept Hlth Care & Epidemiol, Vancouver, BC V6T 1W5, Canada
关键词
D O I
10.1016/S0140-6736(06)69162-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:531 / 536
页数:6
相关论文
共 65 条
[11]   Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients [J].
Coté, HCF ;
Brumme, ZL ;
Craib, KJP ;
Alexander, CS ;
Wynhoven, B ;
Ting, LL ;
Wong, H ;
Harris, M ;
Harrigan, PR ;
O'Shaughnessy, MV ;
Montaner, JSG .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (11) :811-820
[12]   Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA [J].
Cu-Uvin, S ;
Caliendo, AM ;
Reinert, S ;
Chang, A ;
Juliano-Remollino, C ;
Flanigan, TP ;
Mayer, KH ;
Carpenter, CCJ .
AIDS, 2000, 14 (04) :415-421
[13]   Confronting the emergence of drug-resistant HIV type 1: Impact of antiretroviral therapy on individual and population resistance [J].
Daar, ES ;
Richman, DD .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2005, 21 (05) :343-357
[14]   Prevention of mother-to-child HIV transmission in resource-poor countries - Translating research into policy and practice [J].
De Cock, KM ;
Fowler, MG ;
Mercier, E ;
de Vincenzi, I ;
Saba, J ;
Hoff, E ;
Alnwick, DJ ;
Rogers, M ;
Shaffer, N .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09) :1175-1182
[15]  
*DEP HHS, 2006, GUID US ANT AG HIV 1
[16]   Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan [J].
Fang, CT ;
Hsu, HM ;
Twu, SJ ;
Chen, MY ;
Chang, YY ;
Hwang, JS ;
Wang, JD ;
Chuang, CY .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (05) :879-885
[17]   Maternal plasma human immunodeficiency virus type 1 RNA level: A determinant and projected threshold for mother-to-child transmission [J].
Fang, GW ;
Burger, H ;
Grimson, R ;
Tropper, P ;
Nachman, S ;
Mayers, D ;
Weislow, O ;
Moore, R ;
Reyelt, C ;
Hutcheon, N ;
Baker, D ;
Weiser, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (26) :12100-12104
[18]   Community-based approaches to HIV treatment in resource-poor settings [J].
Farmer, P ;
Léandre, F ;
Mukherjee, JS ;
Claude, MS ;
Nevil, P ;
Smith-Fawzi, MC ;
Koenig, SP ;
Castro, A ;
Becerra, MC ;
Sachs, J ;
Attaran, A ;
Kim, JY .
LANCET, 2001, 358 (9279) :404-409
[19]   Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy [J].
Furtado, MR ;
Callaway, DS ;
Phair, JP ;
Kunstman, KJ ;
Stanton, JL ;
Macken, CA ;
Perelson, AS ;
Wolinsky, SM .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (21) :1614-1622
[20]   Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV [J].
Gallant, JE ;
DeJesus, E ;
Arribas, JR ;
Pozniak, AL ;
Gazzard, B ;
Campo, RE ;
Lu, B ;
McColl, D ;
Chuck, S ;
Enejosa, J ;
Toole, JJ ;
Cheng, AK .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (03) :251-260